14 Nov 2025 | 3 Mins Read
Zydus Lifesciences gets USFDA approvals
Flipitmoney
Zydus Lifesciences received final USFDA approval for its Diroximel Fumarate capsules (231 mg), a generic of Vumerity, used to treat multiple sclerosis in adults. The product will be manufactured at its Ahmedabad site and has annual US sales of $999.4 million. This approval is Zydus' 426th USFDA nod out of 487 ANDA filings.